Indicators

Markets:

News

Latest News about CLDX

Recent news which mentions CLDX

< Previous 1 2 3 Next >

Read How Cantor Views Celldex Therapeutics' Barzolvolimab Data

July 05, 2022

Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday

July 05, 2022

HC Wainwright & Co. Maintains Buy Rating for Celldex Therapeutics: Here's What You Need To Know

July 01, 2022

Why Is Akebia Therapeutics Surging By 28%? 48 Stocks Moving In Friday's Mid-Day Session

July 01, 2022

Celldex's Barzolvolimab Shows Rapid, Durable Responses In Early Urticaria Study

July 01, 2022

Why U.S. Stocks Are Trading Higher, Manufacturing Report And More

July 01, 2022

Recap of Tuesday's Biotech Catalysts - End of the Day Summary

June 21, 2022

Stocks That Hit 52-Week Lows On Thursday

June 02, 2022

Stocks That Hit 52-Week Lows On Wednesday

June 01, 2022

77 Biggest Movers From Yesterday

June 01, 2022

7 Micro-Cap Stocks to Buy and Hold for the Next 10 Years

May 11, 2022

Celldex Therapeutics: Q4 Earnings Insights

February 28, 2022

Earnings Scheduled For February 28, 2022

February 28, 2022

12 Health Care Stocks Moving In Friday's Pre-Market Session

October 15, 2021

The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout

October 05, 2021

The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug

September 29, 2021

Benzinga's Top Ratings Upgrades, Downgrades For September 17, 2021

September 17, 2021

Benzinga's Top Ratings Upgrades, Downgrades For September 10, 2021

September 10, 2021

The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test

September 10, 2021

The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization

September 09, 2021

The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod

September 08, 2021

The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself

September 03, 2021

The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab

September 02, 2021

The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering

September 01, 2021

The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical

August 31, 2021

The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration

August 27, 2021

The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO

August 26, 2021

The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug

August 25, 2021

The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal

August 24, 2021

Stocks That Hit 52-Week Highs On Monday

August 23, 2021

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.